About EvoEndo
EvoEndo is a Healthcare company based in Englewood (United States) founded in 2017 by Joel Friedlander. A medical device for un-sedated pediatric endoscopy is developed. It operates on a HealthTech and Direct-to-Consumer (D2C) model. EvoEndo has raised $20.75 million across 4 funding rounds from investors including Gastro, Varia Ventures and TLP Investments. Its chief executive, as recorded, is Jonathan Hartmann. EvoEndo offers products and services including EvoEndo Endoscopy System and Ultra-Thin Endoscopes. Its focus areas include Medical Devices and Endoscopy Equipment. Its legal entity is EvoEndo, Inc. Its competitors include Auris Health and NeoGuide Systems; 2 of its 2 listed competitors have raised funding.
Company details
EvoEndo is dedicated to providing innovative sedation-free endoscopy systems, primarily for pediatric and adult patients. The company offers the FDA-cleared EvoEndo Endoscopy System, designed for transnasal and transoral procedures without sedation. Solutions are developed to enhance patient experience by reducing risks and recovery time. The healthcare sector is served through advanced medical devices that align with evolving care standards, such as the 2025 ACG Guidelines for Eosinophilic Esophagitis (EoE).
- Headquarters Englewood, United States
- Founders Joel Friedlander
- SectorsHealthcare
- Website evoendo.com
- Social LinkedIn X Facebook YouTube
- Legal Name Evoendo, Inc.
- Total Equity Funding$20.75M (USD)
in 4 rounds
- Latest Funding Round$2.25M (USD), Series A
Aug 2024
- InvestorsGastro
& 2 more
Products & Services of EvoEndo
EvoEndo offers a comprehensive portfolio of products and services, including EvoEndo Endoscopy System and Ultra-Thin Endoscopes.
Designed for sedation-free pediatric and adult endoscopy.
High-performance scopes for small anatomy endoscopy procedures.
Apps and channels of EvoEndo
its YouTube channel EvoEndo Inc has 25.3M subscribers and 11 videos.
Videos from EvoEndo
The most watched videos on EvoEndo's YouTube channel, EvoEndo Inc (25.3M subscribers). Click a video to play it here.
More on EvoEndo Inc.
Funding Insights of EvoEndo
EvoEndo has successfully raised a total of $20.75M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $2.25 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20.75M
- Total Rounds 4
- Last Round Series A — $2.25M
- First Round $10.1M
(Jun 2021)
- Investors Count 3
All 4 funding rounds of EvoEndo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | $2.25M | Series A | – | – | – |
| Apr 2023 | Series A | – | Gastro, Varia | – | |
| Apr 2022 | $8.4M | Series A | – | TLP Invest | – |
| Jun 2021 | $10.1M | Series A | – | – | – |
3 investors in total: 3 institutional.
Investors in EvoEndo
EvoEndo has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gastro, Varia Ventures and TLP Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A gastroenterology organization is based in the United States. | gastro.org | United States | ||
Venture capital funds are managed by Varia Ventures. | varia.com | Buffalo, United States | ||
Capital is invested by TLP Investments for economic and social impact. | tlpinvest.com | Libertyville, United States |
Investor details for EvoEndo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EvoEndo
20 people are tracked at EvoEndo (9 in leadership, 6 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Joel Friedlander | Co-Founder | Leadership |
Joshua Goldberg | Director of Sales | Leadership |
Eleanor O'Brien | Director Of Sales | Leadership |
Jonathan Hartmann | CEO | Leadership |
Heather Underwood | CEO | Leadership |
Matt Hunsaker | Director Of Sales, West | Leadership |
Jonathan T. Hartmann | Chief Executive Officer | Leadership |
Ryan Hartman | COO | Leadership |
Amy Carver | Regional Sales & Market Development Director | Leadership |
Jeff Harrington | Board Member | Board & advisors |
Dave Bunning | Board Member | Board & advisors |
Betsy J. Lahue | Board Member | Board & advisors |
Chris Rowland | Chairman | Board & advisors |
Donna Ford-Serbu | Board Member | Board & advisors |
Carl Traynor | Board Member | Board & advisors |
Ridhima Sharma | Marketing Communications Manager | Team |
Clint Smith | Clinical Specialist Manager | Team |
Paula Henry | Senior Project Manager | Team |
Jeremy Rahman | Market Development Manager | Team |
Paul Imaoka | SVP, Manufacturing & Operations | Team |
Complete people profiles for EvoEndo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EvoEndo
3 dated milestones of EvoEndo across 7 years, from founding to its latest funding, stage changes and deals.
- Founded EvoEndo is founded.
- Funding First funding round of $10.1M.
- Funding Latest funding round, Series A, of $2.2M.
Competitors of EvoEndo
EvoEndo has 2 listed competitors in our database, 2 of them funded. They include Auris Health and NeoGuide Systems.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aurishealth.com | 2007 | Redwood, United States | $733.62M | 242 | Robotic microsurgical systems for endoscopy are developed. | |
| neoguidesystems.com | 2000 | San Jose, United States | $39M | Robotic endoscopic technology |
Detailed competitors of EvoEndo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EvoEndo
The website of EvoEndo (evoendo.com) receives about 2K visits a month.
- Monthly visits2K
▼ 7.9% vs previous month
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as EvoEndo (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Evoendo
Complete news archive for EvoEndo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EvoEndo
EvoEndo was founded in 2017 and raised its 1st funding round 4 years after it was founded.
EvoEndo is headquartered in Englewood, United States. It is registered at Englewood, New Jersey, United States.
Jonathan Hartmann is the CEO of EvoEndo, as recorded in our data.
EvoEndo is a funded company, having raised a total of $20.75M across 4 funding rounds to date. The company's 1st funding round was a Series A of $10.1M, raised on Jun 2021.
EvoEndo is dedicated to providing innovative sedation-free endoscopy systems, primarily for pediatric and adult patients. The company offers the FDA-cleared EvoEndo Endoscopy System, designed for transnasal and transoral procedures without sedation. Solutions are developed to enhance patient experience by reducing risks and recovery time. The healthcare sector is served through advanced medical devices that align with evolving care standards, such as the 2025 ACG Guidelines for Eosinophilic Esophagitis (EoE).
EvoEndo's top competitors include Auris Health and NeoGuide Systems.
EvoEndo offers EvoEndo Endoscopy System and Ultra-Thin Endoscopes.
EvoEndo has 3 investors. Key investors include Gastro, Varia Ventures, and TLP Investments.
EvoEndo operates through Evoendo, Inc..